Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection
By Emilie Ruscoe · October 22, 2024, 8:58 PM EDT
Current and former officers and directors of dermatological medication maker Verrica Pharmaceuticals Inc. face a shareholder derivative action alleging the company concealed a "litany of issues" with a manufacturer's facility that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login